Also, APOBEC3B has recently been verified to be a marker of pure prognosis and poor outcomes for ER+ breast cancer, which strongly suggests that genetic aberrations induced by APOBEC3B contribute to breast cancer progression [35]. This evidence concerns the gene APOBEC3B and breast carcinoma.